Symberix vs Synnovation Therapeutics
Synnovation Therapeutics
A precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers
52 employees · est. 2021 · Wilmington, United States
Symberix is the older company (2013 vs 2021); Synnovation Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Symberix | Synnovation Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2021 |
| Headquarters | ||
| Headquarters | United States | Wilmington, United States |
| Employees | ||
| Employees | 3 | 52 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series A |
| Total Funding | ||
| Total Funding | Not tracked yet | $139.00M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 3 |
| Services | ||
| Services | Not tracked yet | Discovery and development of targeted medicines, Building novel small molecule therapies, Advancing therapies into clinical trials |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with specific therapeutic needs, Healthcare providers, Medical research institutions |
| Taxonomy | ||
| Taxonomy | MicrobiomeDrug DiscoveryPharmaceuticalsSymbiotic DrugsGI DiseasesCancer Therapeutics +8 | Precision OncologySmall Molecule TherapiesCancer BiologyMedicinal ChemistryTargeted TherapiesPharmacology +9 |
| Website | ||
| Website | symberix.com | synnovationtx.com |
About Symberix
Symberix is an early-stage biotechnology startup with a vision to revolutionize pharmaceutical control of the microbiome. The company, founded in 2013 as a spin-out of the University of North Carolina at Chapel Hill, is focused on pioneering the development of symbiotic drugs that aim to improve hum...
About Synnovation Therapeutics
Synnovation Therapeutics, founded in 2021, is a rising player in the Biotechnology sector, with a particular focus on Health Care and Life Sciences. Headquartered in the United States, the company is carving a niche in precision oncology by developing small molecule therapies optimized to target key...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Symberix and Synnovation Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Symberix or Synnovation Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Symberix with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Symberix on 12 Sep 2024, and Synnovation Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
